Abstract
We report a case of resistance development toward cefiderocol in a patient with intra-abdominal and bloodstream infections caused by carbapenemase-producing Enterobacter cloacae within 21 days of cefiderocol therapy. Whole genome sequencing revealed heterogeneous mutations in the cirA gene, encoding a catecholate siderophore receptor, conferring phenotypic resistance to cefiderocol.
| Original language | English |
|---|---|
| Journal | Clinical Infectious Diseases |
| Volume | 74 |
| Issue number | 5 |
| Pages (from-to) | 905-908 |
| Number of pages | 4 |
| ISSN | 1058-4838 |
| DOIs | |
| Publication status | Published - 01.03.2022 |
Fingerprint
Dive into the research topics of 'Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver